Ticker Symbol: PRPH
ProPhase Labs Inc
$6.12 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0000868278
Company Profile
ProPhase Labs is a diversified medical science and technology company with deep experience with OTC consumer healthcare products and dietary supplements. The Company is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States. This includes the development and marketing of dietary supplements under the TK Supplements® brand. The Company is also developing ProPhase Diagnostics, Inc. ("ProPhase Diagnostics") to offer COVID-19 and other Respiratory Pathogen Panel (RPP) Molecular tests. The Company also continues to actively pursue strategic investments and acquisition opportunities for other companies, technologies and products.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.prophaselabs.com
CEO: N/A
Tags:
- Consumer Non-Durables
- Household/Personal Care
- Health Technology
- Pharmaceuticals: Major
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:30 PM EST
Previous Close: $4.36
Change:
-$0.02
(
-0.46%)
Days Range: $4.36 - $4.62
Beta: 0.34
52wk. High: $12.69
52wk. Low: $4.05
Ytd. Change -54.97%
50 Day Moving Average: $4.43
200 Day Moving Average: $6.72
Shares Outstanding: 16845029
Valuation
Market Cap: 7.3B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A